2096 — Simcere Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapHigh Flyer

Annual balance sheet for Simcere Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	3,274	2,183	2,623	2,018	1,943
Net Total Accounts Receivable
Net Total Receivables	1,915	2,436	2,379	2,695	2,764
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	6,467	4,980	5,458	5,639	5,466
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,128	1,931	2,139	2,170	2,270
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	10,943	10,161	10,789	10,854	11,510
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,497	3,064	2,967	2,686	2,727
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	5,642	3,724	3,657	3,631	4,442
Common Stock
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	5,302	6,437	7,132	7,223	7,068
Total Liabilities & Shareholders' Equity	10,943	10,161	10,789	10,854	11,510
Total Common Shares Outstanding